WIM
TTOO

WealthPlan Investment Management’s T2 Biosystems, Inc TTOO Stock Holding History

WealthPlan Investment Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$9K Buy
+5
New +$10.6K ﹤0.01% 381

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthPlan Investment Management's TTOO Position: Q1 2022 in Review

WealthPlan Investment Management opened a new position in T2 Biosystems, Inc (TTOO) in Q1 2022: 5 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #381 among its holdings.

67 funds tracked by Wall St. Rank hold TTOO as of Q1 2022.

  • WealthPlan Investment Management held 5 shares of T2 Biosystems, Inc worth $9K as of Q1 2022.
  • T2 Biosystems, Inc was a new WealthPlan Investment Management position in Q1 2022.
  • T2 Biosystems, Inc made up ﹤0.01% of WealthPlan Investment Management's portfolio in Q1 2022, its #381 holding.
  • 67 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2022.

Based on WealthPlan Investment Management's 13F filing for Q1 2022, filed 7 Sep 2022.